Breaking News, Promotions & Moves

Eli Lilly and Co.

Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research Laboratories, will retire, effective February 28, 2010.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research Laboratories, will retire, effective February 28, 2010. Jan M. Lundberg, Ph.D., executive vice president and head of global discovery research, AstraZeneca, will succeed Dr. Paul. Dr. Lundberg plans to join Lilly in Indianapolis as early as January 2010. “Under Steve’s leadership, we now have the most robust pipeline in Lilly’s history, including approximately 60 unique pote...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters